MedTrace Logo

HINTEGRA Total Ankle Prosthesis Follow-up

NCT01284972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2012-10-10

No results posted yet for this study

Summary

The Hintegra® Total Ankle Prosthesis is a non constrained, three-component prosthesis that consists of a flat tibial component, an anatomically-shaped talar component, and a high-density polyethylene inlay. The Hintegra ankle was specifically developed as an attempt to address the needs of minimal bone resection, extended bone support, proper ligament balancing, and minimal contact stressed within and around the prosthesis.

The objective of this study is to evaluate the safety and efficacy of the HINTEGRA® Total Ankle prosthesis at short and mid term follow up.

Conditions

  • Total Ankle Prosthesis

Sponsors & Collaborators

  • Integra LifeSciences Services

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Austria
  • Canada
  • France
  • Germany
  • South Korea
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01284972 on ClinicalTrials.gov